Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants
- PMID: 19017445
Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants
Abstract
This document outlines the consensus agreement from the Union's BCG Working Group regarding BCG vaccination in HIV-infected infants, in response to recently revised World Health Organization (WHO) guidelines, which make HIV infection in infants a full contraindication to bacille Calmette-Guérin (BCG) vaccination. BCG is one of the most widely given vaccines globally and is safe in immunocompetent individuals. Recent evidence shows that HIV-infected infants who were routinely vaccinated with BCG at birth, when asymptomatic, and who later developed AIDS, are at high risk of developing disseminated BCG disease (estimated incidence 407-1300 per 100 000). The document outlines requirements to implement selective BCG vaccination strategies in infants born to HIV-infected women and strategies to reduce the risk of vertical HIV transmission and disseminated BCG disease in infants.
Similar articles
-
The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.Vaccine. 2007 Jan 2;25(1):14-8. doi: 10.1016/j.vaccine.2006.07.020. Epub 2006 Aug 1. Vaccine. 2007. PMID: 16959383
-
Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.Clin Infect Dis. 2006 Feb 15;42(4):548-58. doi: 10.1086/499953. Epub 2006 Jan 11. Clin Infect Dis. 2006. PMID: 16421800
-
BCG-itis in two antiretroviral-treated HIV-infected infants.Int J STD AIDS. 2010 Sep;21(9):662-3. doi: 10.1258/ijsa.2010.010267. Int J STD AIDS. 2010. PMID: 21097744
-
Bacillus Calmette-Guérin complications in children born to HIV-1-infected women with a review of the literature.Pediatrics. 1995 Mar;95(3):414-8. Pediatrics. 1995. PMID: 7862483 Review.
-
[HIV-infection, AIDS and BCG vaccination].Kekkaku. 1993 Jun;68(6):435-44. Kekkaku. 1993. PMID: 8341039 Review. Japanese.
Cited by
-
Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal.Heliyon. 2024 Feb 14;10(4):e26193. doi: 10.1016/j.heliyon.2024.e26193. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38404880 Free PMC article. Review.
-
Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults.J Clin Invest. 2024 Jan 9;134(6):e169060. doi: 10.1172/JCI169060. J Clin Invest. 2024. PMID: 38194272 Free PMC article. Clinical Trial.
-
Immunogenicity and Efficacy of Vaccination in People Living with Human Immunodeficiency Virus.Viruses. 2023 Aug 30;15(9):1844. doi: 10.3390/v15091844. Viruses. 2023. PMID: 37766251 Free PMC article. Review.
-
BCG vaccination strategies against tuberculosis: updates and perspectives.Hum Vaccin Immunother. 2021 Dec 2;17(12):5284-5295. doi: 10.1080/21645515.2021.2007711. Epub 2021 Dec 2. Hum Vaccin Immunother. 2021. PMID: 34856853 Free PMC article. Review.
-
Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings.Front Immunol. 2021 Mar 4;12:635985. doi: 10.3389/fimmu.2021.635985. eCollection 2021. Front Immunol. 2021. PMID: 33746974 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical